| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 19
| Issue : 1 | Page : 1-4 |
|
|
The interrelationship between diabetes mellitus and COVID-19
Thekra Abdulaali Abed1, Zainab Adil Ghani Chabuck2
1 Department of Biology, College of Sciences, University of Babylon, Babylon, Iraq
2 Department of Medical Microbiology, College of Medicine, University of Babylon, Babylon, Iraq
Correspondence Address:
Zainab Adil Ghani Chabuck
Department of Medical Microbiology, College of Medicine, University of Babylon, Babylon
Iraq
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/MJBL.MJBL_11_22
|
|
|
The pandemic of coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than 100 million individuals, including more than 2 million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in patients with COVID-19. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
